Method of preventing withdrawal symptoms associated with the ces

Details Method of preventing withdrawal symptoms associated with the ces Method of preventing withdrawal symptoms associated with the ces

1984-03-02

1986-05-13

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31415

Patent

active

045887390

ABSTRACT:
In human subjects accustomed to smoking tobacco the withdrawal symptoms associated with the cessation or reduction of tobacco smoking may be prevented by administering to the subject an effective amount of an alpha-2 adrenergic agonist such as clonidine hydrochloride for a suitable period of time.
Alternatively, such withdrawal symptoms may be prevented by administering to such a person an effective amount of alprazolam.

REFERENCES:
patent: 4255439 (1981-03-01), Cooper
patent: 4382946 (1983-05-01), Sjoendsma
Internal Medicine Alert 6:85 (1984).
Glassman, A. H. et al.: Science 226: 864-866 (1984).
Modern Drug Encyl. & Therapeutic Index, 14th (1977), pp. 193-195.
Chem. Abst. vol. 97, Chem. Subj. Index, CH.fwdarw.IO (1982), 3314cs.

Affiliated with

Also associated with

Rating

Method of preventing withdrawal symptoms associated with the ces does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of preventing withdrawal symptoms associated with the ces, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing withdrawal symptoms associated with the ces will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1770370